id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2176352,2cffb37f-f4c9-4451-b930-0affe4d91959,3T,"PD FRAZER CONSULTING, INC.",65998,CANADA INTERNATIONAL PHARMACY ASSOCIATION,2018,third_quarter,PHA,"Support intent of H.R.1480 Safe and Affordable Drugs from Canada Act of 2017
Support intent of S.92 Safe and Affordable Drugs from Canada Act of 2017
Support intent of H.R. Affordable and Safe Prescription Drug Importation Act
Support of S.469 Affordable and Safe Prescription Drug Importation Act","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,1,2018-07-31T16:23:44.210000-04:00
2176881,1fb42e2c-d26a-4f0d-93c6-6502f2a71a9e,3T,LINCOLN PARK GROUP L.L.C.,401104374,"PD FRAZER CONSULTING, INC. ON BEHALF OF CANADA INTERNATIONAL PHARMACY ASSOC.",2018,third_quarter,PHA,Support intent of H.R.1480 Safe and Affordable Drugs from Canada Act of 2017 Support intent of S.92 Safe and Affordable Drugs from Canada Act of 2017 Support intent of H.R. Affordable and Safe Prescription Drug Importation Act Support of S.469 Affordable and Safe Prescription Drug Importation Act; HR 5752 Stop Illicit Drug Importation Act.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2018-08-03T09:48:36.853000-04:00
2179531,4d93e9e1-902b-4f97-980a-bdd5312e3704,Q3,RED+BLUE STRATEGIES,400693064,EXPRESS SCRIPTS INC.,2018,third_quarter,PHA,"S. 2553 - Know the Lowest Price Act of 2018- Support of the elimination of ""gag clauses"" in Medicare Part D.

S. 2554 - Patient Right to Know Act - Support of the elimination of ""gag clauses"" in private market drug benefits.

H.R. 6 - Support for Patients and Communities Act - Issues related to ensuring safe prescribing of opioids and other pharmaceuticals that can drive addiction.

S. 3120 - Helping to End Addition and Lessen Substance Use Disorders Act - Issues related to ensuring safe prescribing of opioids and other pharmaceuticals that can drive addiction.

S. 2460/H.R. 3528 - Every Prescription Conveyed Securely Act - support for a bill that would require electronic prescribing for opioids.

CMS regulations related to the Medicare Part D program and role of Prescription Drug Plans. 

S. 637 - Creating Transparency to have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices.

S. 771 - A bill to Improve Access to Affordable Prescription Drugs - Issue related to bringing drug pricing down including better policies in the Part D coverage gap, couponing and advancing biosimilars. 

H.R. 3447 - Furthering Access to Coordinated Treatment for Seniors (FACTS) Act of 2017 - Working to explain the need for safe and confidential data sharing between Medicare part A, B, and D to ensure better coordination of patient care.

Issues related to Direct and Indirect Renumeration policies and their impact on consumers. 

The Trump Administration's Blueprint for Controlling Prescription Drug Prices - Issues related to the role PBMs can play in controlling the price of prescription medications in the United States.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2018-10-02T15:21:15.300000-04:00
2179545,fde830ae-0354-45e8-b7a3-283aec7ad0d6,Q3,RED+BLUE STRATEGIES,400693064,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA),2018,third_quarter,PHA,"H.R. 6 - Support for Patients and Communities Act - Support for policies that help to fight the opioid epidemic with a focus on safe prescriptions.

S. 3120 - Helping to End Addiction and Lessen Substance Use Disorders Act - Support for policies that help to fight the opioid epidemic with a focus on safe prescriptions.

H.R. 3528/S. 2460 - Every Prescription Conveyed Securely Act - Support for electronic prescribing of opioids to enhance patient safety. 

S. 2553 - Know the Lowest Price Act of 2018 - Support for the elimination of "" gag clauses"" in the Medicare Part D program.

S. 2554 - Patient Right to Know Act Drug Prices Act of 2018 - Support for for the elimination of ""gag clauses"" in the private insurance market.

CMS Regulations related to the Medicare Part D program and Prescription Drug Plans(PDPs).

S. 637 - Creating Transparency to Have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices. 

S. 771 - A Bill to Improve Access to Affordable Prescription Drugs - Issues related to bringing drug prices down including strengthening policies in the Part D coverage gap, couponing and advancing biosimilars. 

Education activities for Members and staff related to Direct and Indirect Renumeration(DIR)policies. 

Education activities related to the cross referencing of certain data related to Medicare Parts A, B and D.  

Trump Administration's Blueprint for lowering the price of prescription medications in the United States and the role that PBMs can play in doing so.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2018-10-02T15:38:20.660000-04:00
2179548,88d28e1e-52e8-475f-b12b-b7f5e3f0a3d3,Q3,RED+BLUE STRATEGIES,400693064,PEW CHARITABLE TRUSTS,2018,third_quarter,PHA,"H.R. 6 - Support for Patients and Communities Act - Support for policies that help to fight the opioid epidemic with a focus on public health.

S. 3120 - Helping to End Addiction and Lessen Substance Use Disorders Act - Support for policies that help to fight the opioid epidemic with a focus on public health.

S. 2315 - The Over the Counter Drug Safety Innovation and Reform Act - Support for amending and improving OTC Monograph Reform.

S. 2852 - the Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2018 - Issues related to the continues attention required to antibiotic resistance as a public health threat and policies to ensure the adequacy and development of antibiotics to ward against threats to the common good. 

Trump Administration's Blueprint for lowering the price of prescription medications in the United States. 

CMS regulations related to Medicare Part D and promulgation of laws related to curbing substance use disorder among Medicare beneficiaries. 

H.R. 2871 - The Preserving Patient Access to Compounded Medications Act of 2017 - Concerns about how the bill could compromise safety protocols for compounded medications. 

Issues related to antibiotic innovation and advancement

Issues related to over the counter medications and supplements.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-10-02T15:42:21.617000-04:00
2179867,84d99f14-21e9-4ae0-a546-98f9a622f3e3,Q3,AMERICAN CAPITOL GROUP,305852,CARDINAL HEALTH,2018,third_quarter,PHA,Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services;,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-10-03T16:16:03.210000-04:00
2179884,a7a6840c-8ca1-43d7-918e-d88495661dc1,Q3,HB STRATEGIES,401104718,BAYER U.S. LLC,2018,third_quarter,PHA,"Issues related to tax, trade and pharmaceutical policy","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2018-10-03T16:29:12.197000-04:00
2179901,724542db-bc37-41c5-939c-75a3edc0153d,Q3,COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE,11003,COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE,2018,third_quarter,PHA,CCAGW and NTU Regarding H.R. 6642,"HOUSE OF REPRESENTATIVES,SENATE",,40000,0,0,2018-10-03T16:59:21.467000-04:00
2180294,12475c5c-2f50-489f-9a22-414f81138698,Q3,"CHATMAN, LLC",400678024,LIVINGSTON GROUP FOR RUSH UNIVERSITY MEDICAL CENTER,2018,third_quarter,PHA,Support 340B program in HRSA.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-10-04T20:02:19.630000-04:00
2180297,8943b13c-aba5-4eec-9312-89452f6bc2f2,3A,"CHATMAN, LLC",400678024,LIVINGSTON GROUP FOR RUSH UNIVERSITY MEDICAL CENTER,2018,third_quarter,PHA,Support 340B program in HRSA.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-10-04T20:14:20.663000-04:00
2180353,cd919f2b-59b8-44cc-b9dc-10b8e7315ac3,Q3,KATE MOSS,25988,CVS HEALTH,2018,third_quarter,PHA,Legislation impacting PBMs and drug pricing,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2018-10-05T09:50:59.723000-04:00
2180565,d64f6b6a-1f98-472a-a7f9-853fbbd31b47,Q3,PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION,401103605,PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION,2018,third_quarter,PHA,"Answered questions about opioid manufacturing/packaging, discussed potential solutions to drug shortage situations, and provided general education about the pharma/biopharma contract services sector.","HOUSE OF REPRESENTATIVES,SENATE",,50000,0,0,2018-10-05T14:59:13.197000-04:00
2180666,ea300b8b-3082-4a74-8907-9b730ec334f0,Q3,BROYDRICK & ASSOCIATES,7268,EXELA PHARMA SCIENCES,2018,third_quarter,PHA,"Drug shortages and FDA approval, USTR acceptance.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2018-10-05T18:23:11.293000-04:00
2180680,b402a913-d411-42bd-a853-eb99d3843fe0,Q3,BROYDRICK & ASSOCIATES,7268,TONIX PHARMACEUTICALS,2018,third_quarter,PHA,Funding for a new drug for PTSD.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2018-10-05T18:38:21.623000-04:00
2180929,f7cc014e-b53b-42c1-9be6-ecb93cb7869f,Q3,AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION,401103437,AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION,2018,third_quarter,PHA,FDA Listening Session on Compounding,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2018-10-08T15:27:07.087000-04:00
2181116,61fbbf6e-5870-49bb-b3a5-341437eec39d,Q3,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2018,third_quarter,PHA,Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,144981,0,0,2018-10-09T10:59:25.970000-04:00
2181134,be459d23-1aae-446b-9362-5043b2705bc1,Q3,SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING,35968,SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING,2018,third_quarter,PHA,Compounding of radiopharmaceuticals.,"Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE",,30000,0,0,2018-10-09T11:24:35.817000-04:00
2181224,51359e3b-c249-4194-8927-9717c4f7449f,Q3,MR. VINCENT A. PANVINI,401008845,PHRMA,2018,third_quarter,PHA,Medicare Part D,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2018-10-09T12:25:19.510000-04:00
2181276,e8f89747-6fc9-4fa2-b03a-a019db66fbac,Q3,MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP),24486,INOVIO PHARMACEUTICALS,2018,third_quarter,PHA,"Government Relations Services including developing strategies to achieve legislative goals, inclusion of MERS on list of neglected diseases at FDA","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-10-09T13:43:54.990000-04:00
2181348,da4c9d4b-9483-4de9-b45c-c20e19e458e5,Q3,TAUZIN STRATEGIC NETWORKS,400786367,CAPTURERX,2018,third_quarter,PHA,Issues related to the 340b program,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2018-10-09T14:23:31.820000-04:00
2181698,9a04aeed-86b3-41fc-96ba-2670e50223b8,Q3,THE KUTLER GROUP,401103966,PRIME THERAPEUTICS,2018,third_quarter,PHA,"Patient Right to Know Drug Prices Act
Prescription Transparency Act
CREATES Act","HOUSE OF REPRESENTATIVES,SENATE",24000,,0,0,2018-10-10T10:21:18.097000-04:00
2181938,42629887-8f5d-4168-a84d-70bba16a0156,Q3,BROWN RUDNICK LLP,287895,PRIME THERAPEUTICS,2018,third_quarter,PHA,S. 2554-Patient Right to Know Drug Prices Act; H.R. 5343-Prescription Transparency Act of 2018.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-10-10T13:27:42.463000-04:00
2182119,dd1bb0c4-1b35-4848-9176-889265878484,Q3,ROWLAND STRATEGY GROUP LLC,401104274,RAI SERVICES COMPANY,2018,third_quarter,PHA,"Departments of Labor, Health and Human Services, and Related Agencies appropriations; provisions
related to innovative response platforms for vaccines and drugs.","HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2018-10-10T16:45:38.090000-04:00
2182222,3a35f6ab-dcc9-499f-80ec-c9909ba942e2,Q3,WAXMAN STRATEGIES,401103693,340B HEALTH,2018,third_quarter,PHA,"Issues affecting the 340B drug pricing program; HR 6071 - SERV Communities Act; HR 4392 - To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes; H.R.6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019","HOUSE OF REPRESENTATIVES,SENATE",18750,,0,0,2018-10-11T09:00:57.097000-04:00
2182293,50ac9809-9d19-43e8-96a7-9d77f9cdedc4,Q3,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,26672,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,2018,third_quarter,PHA,"H.R. 1245/S. 469 The Affordable and Safe Prescription Drug Importation Act
H.R. 1316 - Prescription Drug Price Transparency Act
H.R. 749 Lower Drug Costs Through Competition 
H.R.2430/S. 934 - FDA Reauthorization Act of 2017
H.R. 4841 - Standardizing Electronic Prior Authorization for Safe Prescribing Act 
H.R. 6733 - Know the Cost Act
H.R. 6143/ S. 2554  - Patient Right to Know Drug Prices Act
H.R. 6144/ S. 2553  - Know the Lowest Price Act 
H.R. 6641 - True Cost-sharing of Seniors Drugs Transparency (True COST) Act
H.R. 5989 - Fair Pricing Act","Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,440000,0,0,2018-10-11T10:31:39.797000-04:00
2182349,f20c9597-84bf-44dc-b3bc-ef3de7a0a942,Q3,CAPITOL HILL CONSULTING GROUP,72053,PURDUE PHARMA LLP,2018,third_quarter,PHA,Controlled Drug Substances Act (21 USC 13),"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2018-10-11T11:08:03.083000-04:00
2182714,6d1e4738-944b-4ac8-a6be-9f085f36ea90,Q3,WAXMAN STRATEGIES,401103693,MEDICINES360,2018,third_quarter,PHA,Issues impacting the 340B drug discount program; SERV Communities Act HR 6071,HOUSE OF REPRESENTATIVES,,,0,0,2018-10-11T15:35:29.053000-04:00
2182915,8c0f0b30-2aa6-46f2-841b-f8b550a6ce97,Q3,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,312496,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,2018,third_quarter,PHA,"340B drug pricing, PREA, CAR-T","Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",,50890,0,0,2018-10-12T09:20:02.407000-04:00
2183159,7bc43a37-a519-46f5-ada8-e57a65056287,Q3,CONSUMER HEALTHCARE PRODUCTS ASSOCIATION,29403,CONSUMER HEALTHCARE PRODUCTS ASSOCIATION,2018,third_quarter,PHA,"Pseudoephedrine

Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number).

Oral Contraceptives

H.R. 421/S. 93 - Allowing Greater Access to Safe and Effective Contraception Act of 2017. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections.

Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch

Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines.

S. 2825/H.R. 6378 -- Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018. To reauthorize certain programs under the Pandemic and All-Hazards Preparedness Reauthorization Act.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of",,198000,0,0,2018-10-12T11:31:27.360000-04:00
2183285,19017d8e-b16c-49eb-b621-e44550cf6584,Q3,MCDERMOTT+ LLC,401103287,ALLIANCE FOR RURAL HOSPITAL ACCESS,2018,third_quarter,PHA,Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2018-10-12T12:42:12.507000-04:00
2183315,963fc430-23bf-41e5-b72e-09a685245d68,Q3,ACG ADVOCACY,2057,WALGREEN CO.,2018,third_quarter,PHA,"Competition Policy Issues.
Drug Pricing Policy Issues.","Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2018-10-12T12:54:22.727000-04:00
2183588,0092ee42-d90c-4005-bd6f-6eb95d8bd5ce,Q3,ACADEMY OF MANAGED CARE PHARMACY,48793,ACADEMY OF MANAGED CARE PHARMACY,2018,third_quarter,PHA,"Sent a letter in support of S. 974, the CREATES Act to the full Senate and communicated in regard to the bill.  
Dissemination of information in support of H.R. 2026 - Pharmaceutical Information Exchange Act.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,50000,0,0,2018-10-12T16:45:20.873000-04:00
2183736,99a16a6c-8268-420f-bb33-783c447bc803,Q3,INDEPENDENT PHARMACY COOPERATIVE,313098,INDEPENDENT PHARMACY COOPERATIVE,2018,third_quarter,PHA,"Support S. 2553, the Know the Lowest Price Act of 2018, and S. 2554, the Patient Right to Know Drug Prices Act, which give community pharmacists more flexibility in informing patients they could pay less out of pocket for a prescription than by using their health insurance. 
Medicare CONTRACT YEAR 2019 POLICY AND TECHNICAL CHANGES comments. Support all drug price concessions at the point of sale.
Support S. 109/H.R. 592, the Pharmacy and Medically Underserved Areas Enhancement Act
Support S.413/H.R. 1038, the ""Improving Transparency and Accuracy in Medicare Part D Drug Spending Act.
Ensure patient choice in Comprehensive Addiction and Recovery Act of 2016 lock-in provision. 
Support S. 413 / H.R. 1038 the ""Improving Transparency and Accuracy in Medicare Part D Drug Spending Act""","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2018-10-13T10:26:03.607000-04:00
2183771,529d5697-a78a-40d9-874e-cf52c1f70e7f,Q3,THE MATHIS HARPLE GROUP,322911,PILMA,2018,third_quarter,PHA,Medicare Part D Donut Hole,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-10-13T14:06:25.140000-04:00
2183835,21a2ea33-9248-4ee6-8a9f-bf6dea058e42,Q3,BROWN RUDNICK LLP,287895,HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC,2018,third_quarter,PHA,S.469-The Affordable and Safe Prescription Drug Importation Act; Public Law 114-145-The Ensuring Patient Access and Effective Drug Enforcement Act.,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2018-10-14T13:42:03.457000-04:00
2183873,4e54e8c4-998c-4577-9bde-dcb1b71fc0e0,Q3,ROCK & ASSOCIATES,33545,"BRAIDWOOD MANAGEMENT, INC.",2018,third_quarter,PHA,"Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2018-10-14T23:17:25.633000-04:00
2183877,f6d507f2-ad41-4bdb-a986-1e207ecf9d17,Q3,ROCK & ASSOCIATES,33545,DIAMONDBACK DRUGS,2018,third_quarter,PHA,"Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2018-10-14T23:19:26.587000-04:00
2183879,afef92c4-be59-47bb-8f3d-97baca452b70,Q3,ROCK & ASSOCIATES,33545,"VETERINARY PHARMACIES OF AMERICA, INC.",2018,third_quarter,PHA,"Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2018-10-14T23:20:27.400000-04:00
2183883,2e3ff669-3730-404a-bec8-f7846d42ac64,Q3,ROCK & ASSOCIATES,33545,"WEDGEWOOD VILLAGE PHARMACY, INC.",2018,third_quarter,PHA,"Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2018-10-14T23:20:28.120000-04:00
2183885,632c04af-82fb-418e-8446-ed01cfb63a91,Q3,ROCK & ASSOCIATES,33545,WOMEN'S INTERNATIONAL PHARMACY,2018,third_quarter,PHA,"Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2018-10-14T23:21:28.823000-04:00
2183888,dcb08340-7434-4b68-b40d-3e42343990b7,Q3,ROCK & ASSOCIATES,33545,WELLNESS PHARMACY,2018,third_quarter,PHA,"Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2018-10-14T23:22:29.527000-04:00
2183892,c61f3ff2-25ac-4c38-ac52-31406e6a1381,Q3,ROCK & ASSOCIATES,33545,PRECISION PHARMACY,2018,third_quarter,PHA,"Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2018-10-14T23:23:30.307000-04:00
2183915,926d9721-2f7d-450e-baa2-0f16f0a11fd1,Q3,RED+BLUE STRATEGIES,400693064,COHERUS BIOSCIENCES,2018,third_quarter,PHA,Executive and Legislative initiatives to allow the biosimilars market place to succeed in the United States.,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2018-10-15T08:52:44.727000-04:00
2183963,4140b7bb-5c51-4ebe-bdd1-88af6743bc1d,Q3,COVINGTON & BURLING LLP,11195,"FLEXION THERAPEUTICS, INC.",2018,third_quarter,PHA,"Education and support for public policies that promote the development, use, coverage and reimbursement of novel, non-opioid pain therapies, including FDA Opioid Sparing legislation.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-10-15T10:23:11.977000-04:00
2183998,64fa9d70-bff8-4383-9a1c-f89e5b2e3c39,Q3,LUPIN PHARMACEUTICALS INC,401104766,LUPIN PHARMACEUTICALS INC,2018,third_quarter,PHA,"CREATES Act (S.974/H.R.2212) - Addresses REMS and market entry issues.
PACED Act (S.2514) - Restores PTO's authority to review patents despite assertion of sovereign immunity.
CARA 2.0 (S.2456/H.R.5311) - Addresses opioid crisis.","HOUSE OF REPRESENTATIVES,SENATE",,83325,0,0,2018-10-15T10:49:27.650000-04:00
2184970,c81bd0b0-e244-41fd-8d8c-a0284f46b9a1,Q3,"FLYNN & ASSOCIATES, INC.",15020,PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION,2018,third_quarter,PHA,"Childrens Health Insurance Program
Importation of drugs from Canada
Medicare Part D - Rebates","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2018-10-16T09:24:51.567000-04:00
2185016,f4cf3c39-cb6b-4d69-8c75-8b5a073cdd74,Q3,LINCOLN PARK GROUP L.L.C.,401104374,CANADIAN INTERNATIONAL PHARMACY ASSOCIATION,2018,third_quarter,PHA,Support intent of H.R.1480 Safe and Affordable Drugs from Canada Act of 2017 Support intent of S.92 Safe and Affordable Drugs from Canada Act of 2017 Support intent of H.R. Affordable and Safe Prescription Drug Importation Act Support of S.469 Affordable and Safe Prescription Drug Importation Act; HR 5752 Stop Illicit Drug Importation Act; Support of HR 6 Patients and Communities Act.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-10-16T09:55:10.400000-04:00
2185087,7c27bbf3-e77d-4ed0-b064-282b2afe84f4,Q3,"MANATT, PHELPS, AND PHILLIPS",23645,NEKTAR THERAPEUTICS,2018,third_quarter,PHA,FDA oversight of certain pain reliever products,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",108000,,0,0,2018-10-16T10:28:41.107000-04:00
2185184,3e108113-3d7c-4ba0-85b3-a2669d44ef21,Q3,LEHIGH VALLEY HEALTH NETWORK,40041332,LEHIGH VALLEY HEALTH NETWORK,2018,third_quarter,PHA,researching 340 B program,,,,0,0,2018-10-16T11:16:18.427000-04:00
2185327,1f268a32-dc84-47b6-96f1-0bc0459123c1,Q3,ZHF CONSULTING LLC,401103689,"MEDISCA, INC.",2018,third_quarter,PHA,Opioid crisis/alternative pain medication,"HOUSE OF REPRESENTATIVES,SENATE",22500,,0,0,2018-10-16T11:54:09.850000-04:00
2185745,6fe74fae-ce6f-4ff9-b166-a8cf1ea22cb8,Q3,BUCHANAN INGERSOLL & ROONEY PC,55291,"TISSUEGENE, INC.",2018,third_quarter,PHA,"Federal government relations service, strategy development and implementation relating to regenerative medicine products.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-10-16T14:05:00.897000-04:00
2185817,c92bba0a-69dd-414a-8f42-2e8b4b1e9f91,Q3,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,3457,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,2018,third_quarter,PHA,"Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Communication with Congress on compounding. Communicated with House and Senate offices on drug shortages.Communication with DEA on opioid shortage of generic injectables. Support for S. 974, Creating and Restoring Equal Access to Equivalent Samples Act of 2018, and H.R. 6142, Reducing Drug Waste Act of 2018.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE",,290000,0,0,2018-10-16T14:22:28.587000-04:00
2185931,5769b95e-d14a-4f82-9282-a84a5d63ed0f,Q3,ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,58534,ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,2018,third_quarter,PHA,"HR 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes; HR 4710 340B PAUSE Act Any provision(s) reducing or changing the 340B Drug Discount Program or benefits to hospitals limiting hospital access to the benefit and or improving or updating the program's guidelines. 
HR 6082 Overdose Prevention and Patient Safety Act; support treatment options/funding for reduction and treatment of opioid addiction.
Opposition to any provision in any bill to reduce the scope and use of the 340B Drug Discount benefit.","HOUSE OF REPRESENTATIVES,SENATE",,11486,0,0,2018-10-16T14:51:11.357000-04:00
2186266,971c4dab-3b08-4efe-8138-5a8d91691e89,Q3,LUNGREN LOPINA LLC,401103314,AMPAC FINE CHEMICALS,2018,third_quarter,PHA,Fair treatment for US pharmaceutical ingredients,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2018-10-16T15:51:50.333000-04:00
2186299,6dbf9271-1c23-415d-962e-b488280dea0a,Q3,"MERCURY PUBLIC AFFAIRS, LLC",70175,MORRIS AND DICKSON,2018,third_quarter,PHA,IT Help RE Improper Prescriptions,"Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),Justice, Dept of (DOJ),Office of Natl Drug Control Policy (NDCP),White House Office",20000,,0,0,2018-10-16T16:03:06.100000-04:00
2186588,5359526f-1f20-4e31-afc7-700edd12b29f,Q3,MCDERMOTT WILL & SCHULTE LLP,24338,"MAXOR NATIONAL PHARMACY SERVICES, LLC",2018,third_quarter,PHA,"Efforts to monitor and address pharmacy and drug pricing-related legislative and regulatory proposals, including, but not limited to, the 340B Program.","HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",50000,,0,0,2018-10-16T18:03:54.620000-04:00
2186753,56db97d3-cddb-4921-946b-6c43e79a2049,Q3,TRAVERE THERAPEUTICS,401104190,TRAVERE THERAPEUTICS,2018,third_quarter,PHA,"Orphan Drug Act, Drug Quality and Security Act drug safety issues, drug pricing, opioid legislation provisions related to opioid sparing, FAST Generics and CREATES Acts, FDA issues","HOUSE OF REPRESENTATIVES,SENATE",,220000,0,0,2018-10-16T22:45:04.840000-04:00
2186848,d2141923-cfc8-4f86-837f-1214b2b6b79a,Q3,NOVO NORDISK INC.,284790,NOVO NORDISK INC.,2018,third_quarter,PHA,"Issues related to P.L. 115-52 (H.R. 2430/S. 934) FDA Reauthorization Act of 2017 (Prescription Drug User Fee Act VI); H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act; H.R. 1776/S.771 Improving Access To Affordable Prescription Drugs Act; H.R. 4710, the 340B Protecting Access for the Underserved and Safety-Net Entities Act (340 PAUSE Act)and other issues related to 340B program","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,Veterans Affairs, Dept of (VA)",,700000,0,0,2018-10-17T08:52:57.437000-04:00
2186998,728b22c6-a684-4909-9437-3d8cc5bde4e9,3A,ACADEMY OF MANAGED CARE PHARMACY,48793,ACADEMY OF MANAGED CARE PHARMACY,2018,third_quarter,PHA,"Sent a letter in support of S. 974, the CREATES Act to the full Senate and communicated in regard to the bill.  
Dissemination of information in support of H.R. 2026 - Pharmaceutical Information Exchange Act.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,50000,0,0,2018-10-17T10:09:55.870000-04:00
2187005,6679ae1c-7cf2-4f30-80bc-acf724891370,Q3,HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA),28776,HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA),2018,third_quarter,PHA,"Ensuring Patient Access and Effective Enforcement Act (Public Law 114-145); Opioid Abuse - General issues related to opioid abuse (HR6, HR 6779, HR 6600, S 2838; S 2837, S 3120, S 2680, S 3282); Importation of Prescription Drugs (S 469, S 771, HR 1776, HR 1245, HR 934, HR 1480, S 92, S 64), Implementation of Public Law 113-54 (DSCSA)","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,292365,0,0,2018-10-17T10:13:58.777000-04:00
2187076,02c64356-a8dd-4dc0-a623-ac94ec8a67eb,Q3,PUBLIC CITIZEN,32362,PUBLIC CITIZEN,2018,third_quarter,PHA,"S. 2852/HR 3678-Pandemic and all-hazards preparedness and advancing innovation act of 2018, HR 6294-REVAMP Act, Medicare Part D negotiation, prescription drug pricing, HR 6505-Medicare negotiation and competitive licensing act, HR 6577-PRICED act, HR 6576-Drug Price Transparency in Communications act, medicare prescription drug savings and choice act, HR 1223/S 1509 OPEN Act, S 1369-Stop Price gouging act.","HOUSE OF REPRESENTATIVES,Office of Government Ethics (OGE),Securities & Exchange Commission (SEC),SENATE,U.S. Trade Representative (USTR)",,50000,0,0,2018-10-17T10:26:15.573000-04:00
2187086,57abfffe-d7d1-485c-839f-e0d115e84160,Q3,ICE MILLER LLP,67854,ELI LILLLY AND COMPANY,2018,third_quarter,PHA,Issues related to pharmaceutical research and manufacturing,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE,Vice President of the U.S.",,,0,0,2018-10-17T10:28:19.620000-04:00
2187179,16052389-8f22-4052-a030-2412082b615b,Q3,AARP,1694,AARP,2018,third_quarter,PHA,"Discussed efforts to include harmful prescription drug policies in NAFTA with House and Senate staff.

H.R. 2212/ S. 974, CREATES Act - Discussed support of bill.

H.R. 2439/S.1131, FAIR Drug Pricing Act - Discussed support of bill.

S. 124, The Preserve Access to Affordable Generics Act - Discussed support of bill.

Part D Deal in Bipartisan Budget Act, Met with House offices to reiterate our support for the deal; sent multiple letters to House and Senate leadership; discussed support for the deal with House and Senate staff.

Discussed the Presidents Prescription Drug Blueprint and RFI.

S. 1091, the Supporting Grandparents Raising Grandkids Act - Advocated for passage of bill.

S. 2553, Know the Lowest Price Act - Endorsed legislation. 

S.2554, Patient Right to Know Act - Endorsed legislation.

Discussed opioid abuse legislation to address opioid abuse and misuse.

Discussed possible ways to improve Medicare Part D.

Discussed Rx Price Watch Reports and the impact of high drug costs.

Discussed drug pricing reforms AARP supports, including secretarial negotiation, importation, reducing exclusivity for biologics, and ending pay-for-delay deals.

Discussed family caregiving, opioids, and Supporting Grandparents Raising Grandchildren Act (P.L. 115-196, S. 1091/H.R. 3105).","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Federal Highway Administration (FHA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Labor, Dept of (DOL),Natl Highway Traffic Safety Administration (NHTSA),Securities & Exchange Commission (SEC),SENATE,Treasury, Dept of,White House Office",,1740000,0,0,2018-10-17T10:46:51.623000-04:00
2187498,d636c755-9a57-4c37-8f49-c2f1a4c99ae4,Q3,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2018,third_quarter,PHA,"FY 19 appropriations for NIH
Support for 340B program","Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)",,50000,0,0,2018-10-17T11:32:45.247000-04:00
2187603,8dc45e1a-becb-409e-96c5-a5973928ce8e,Q3,NATIONAL HOME INFUSION ASSOCIATION,40047365,NATIONAL HOME INFUSION ASSOCIATION,2018,third_quarter,PHA,"Lobbied on FDA Proposed Draft State Memorandum of Understanding
Lobbied on FDA Proposed Guidance on Insanitary Conditions","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office",,77000,0,0,2018-10-17T11:51:12.030000-04:00
2187633,f202d19b-2391-4f39-8fe6-fa7e900a2719,Q3,"POLITICAL CAPITAL, LLC",401104260,MEDISCA INC,2018,third_quarter,PHA,"DQSA
Oversight
HR  2871","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2018-10-17T11:57:23.423000-04:00
2187644,2f46c19b-1356-4499-a782-d7823988eab9,Q3,"POLITICAL CAPITAL, LLC",401104260,PINE PHARMACEUTICALS,2018,third_quarter,PHA,"Outsourcing Facilities
HR-2871","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2018-10-17T11:59:27.970000-04:00
2187654,0ae2520a-f588-4f15-8a90-5071b7557352,3A,"POLITICAL CAPITAL, LLC",401104260,MEDISCA INC,2018,third_quarter,PHA,"DQSA
Oversight
HR  2871","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-10-17T12:00:31.327000-04:00
2187731,53ff5d4a-7b58-4db4-add1-3fb380f871ea,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,AMERICAN SOCIETY OF HEMATOLOGY,2018,third_quarter,PHA,"HR 1409, Cancer Drug Coverage Parity Act","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2018-10-17T12:31:04.207000-04:00
2187748,10f276ac-ee6f-4630-928d-ec9d41e16227,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,THE HEMOPHILIA ALLIANCE,2018,third_quarter,PHA,Issues related to the 340B drug discount program and drug pricing policies,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-10-17T12:33:08.427000-04:00
2187752,8bf2619a-1bde-4988-918b-9b7539dbc07a,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL ASSOCIATION OF EPILEPSY CENTERS,2018,third_quarter,PHA,Issues related to anti-epileptic drugs.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",10000,,0,0,2018-10-17T12:34:09.927000-04:00
2188280,50690d7e-0f1e-4c39-a91f-ee85b36a493b,Q3,"KOUNTOUPES DENHAM CARR & REID, LLC",320918,BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY),2018,third_quarter,PHA,Issues related to the cost of care and protecting patient access to blood cancer treatment.  Issues related to specialty drug tiers.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2018-10-17T14:40:25.143000-04:00
2188339,b1b0f078-166f-48f0-95d9-06d8763605f9,Q3,MASSACHUSETTS MEDICAL SOCIETY,23975,MASSACHUSETTS MEDICAL SOCIETY,2018,third_quarter,PHA,"S. 771 - Improving Access to Affordable Prescription Drugs - Legislation that seeks to address prescription drug costs by increasing transparency and accountability, boosting access and affordability of key drugs, spurring innovation, and increasing choice and competition by allowing Medicare to negotiate the price of drugs, among other provisions.

Efforts to require the manufacturers suggested retail price of prescription drugs in direct to consumer advertising of prescription drugs - no specific bill","Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,60000,0,0,2018-10-17T14:55:45.677000-04:00
2188355,ecba87b6-1ca0-4bbf-9898-5102d592af6b,Q3,"MEHLMAN CONSULTING, INC.",284950,AMERICA'S HEALTH INSURANCE PLANS,2018,third_quarter,PHA,"Prescription drug pricing.
H.R. 2212 - The CREATES Act.
H.R. 1892 - Bi-partisan Budget Act of 2018; Medicare donut hole coverage.","HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2018-10-17T14:59:52.413000-04:00
2188377,ca822f23-328e-4672-b33e-1bb4616eb35e,Q3,FTI GOVERNMENT AFFAIRS,401054971,PROFESSIONAL COMPOUNDING CENTERS OF AMERICA,2018,third_quarter,PHA,"Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R.2871 ""Preserving Patient Access to Compounded Medication Act of 2017. ""","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2018-10-17T15:01:58.130000-04:00
2188962,8bdea3c4-5eef-4cca-9767-71496f5523e3,Q3,ASCENSION HEALTH,53301,ASCENSION HEALTH,2018,third_quarter,PHA,"Drug pricing; Creating and Restoring Equal Access to Equivalent Samples Act of 2016 (CREATES)
FAIR Drug Pricing Act; Drug pricing; 340B Drug Discount Program;","Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,490000,0,0,2018-10-17T16:18:42.077000-04:00
2189044,b035eb8e-9c57-463e-8112-1f9666bf733a,Q3,THERMO FISHER SCIENTIFIC INC.,323251,THERMO FISHER SCIENTIFIC INC,2018,third_quarter,PHA,Drug shortage prevention,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Food & Drug Administration (FDA),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Veterans Affairs, Dept of (VA),White House Office",,230000,0,0,2018-10-17T16:38:00.407000-04:00
2189132,46b8e9db-d97a-4d1a-8098-b39a749ecac6,Q3,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,27478,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,2018,third_quarter,PHA,"Congressional Oversight of 340 B Program; 
Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; 
Biosimilar naming; 
H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act; 
H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017;
HR 749, Lower Drug Costs through Competition Act;
EPA Proposed Rule: Management Standards for Hazardous Waste Pharmaceuticals","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),Office of Natl Drug Control Policy (NDCP),Office of Personnel Management (OPM),SENATE,Small Business Administration (SBA),Substance Abuse & Mental Health Services Administration (SAMHSA),White House Office",,290000,0,0,2018-10-17T16:57:24.270000-04:00
2189209,7902221c-3005-4343-b5b7-1464f5398b6e,Q3,THE D MAJOR GROUP,401103162,ALLERGAN INC (FORMERLY ACTAVIS INC ),2018,third_quarter,PHA,Monitor issues concerning bioequivalence standards for pharmaceuticals.,"HOUSE OF REPRESENTATIVES,SENATE,White House Office",50000,,0,0,2018-10-17T17:16:37.977000-04:00
2189297,a944eced-bed6-48ea-8090-61558ea52b0c,Q3,"BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.",323876,BLUE CROSS AND BLUE SHIELD OF KANSAS INC,2018,third_quarter,PHA,Opioid Epidemic,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2018-10-17T17:48:03.040000-04:00
2189320,43fb86bc-341f-42c6-8d7f-0962de2d7590,Q3,DAN BURTON INTERNATIONAL LLC,401103789,GRANULES USA INC.,2018,third_quarter,PHA,"Consultant shall pursue an effort to obtain from the United States Food and Drug Administration (FDA) expeditious processing of Client's petition to allow additional sources of API, the active ingredient in ibuprofen, to enter the American market in order to alleviate an anticipated shortage.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-10-17T18:36:12.610000-04:00
2189399,1c9b722c-89ba-445e-9fcc-5e34f95be6f3,Q3,"JOHN T. DOOLITTLE, LLC",400635920,DAN BURTON INTERNATIONAL LLC ON BEHALF OF GRANULES USA INC.,2018,third_quarter,PHA,"Consultant shall pursue an effort to obtain from the United States Food and Drug Administration (FDA) expeditious processing of Client's petition to allow additional sources of API, the active ingredient in ibuprofen, to enter the American market in order to alleviate an anticipated shortage.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-10-17T20:01:36.947000-04:00
2189513,50d4ee4f-01ea-485a-b9ab-f7f4819825c5,Q3,FORGE FEDERAL AFFAIRS LLC,400865535,LILLY USA LLC,2018,third_quarter,PHA,"Issues related to pricing of prescription drugs.
Opposition to prescription drug importation and cuts to Medicare Part D funding.
Support for funding of Department of Homeland Security drug interdiction efforts.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-10-17T22:26:17.507000-04:00
2189756,38fca3c8-8682-43c1-a6b7-8ca2e45a1150,Q3,THE MATHIS HARPLE GROUP,322911,PHRMA,2018,third_quarter,PHA,"Medicare Pt D Donut Hole, USMCA Trade, CHARGE IN Legislation","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-10-18T09:19:51.790000-04:00
2189760,047c58f6-a948-4068-9027-84b0595a04b5,Q3,HOLLAND & KNIGHT LLP,18466,PROTECTING ACCESS TO PAIN RELIEF COALITION,2018,third_quarter,PHA,"Advocating for policy to ensure patient access to pain relief; S.2680, Opioid Crisis Response Act of 2018; H.R. 6, SUPPORT for Patients and Communities Act.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2018-10-18T09:21:54.617000-04:00
2189888,cc43d4ef-4ee5-4b3b-9934-3efd2f3fabe5,3T,"RUBICON ADVISORS, LLC",315091,ALBANY MOLECULAR RESEARCH INC.,2018,third_quarter,PHA,Border Adjustment tax,"HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",10000,,0,1,2018-10-18T09:46:52.043000-04:00
2189911,d8380637-79d6-4e86-999a-ec8ea76801eb,Q3,"RUBICON ADVISORS, LLC",315091,DYNAVAX TECHNOLOGIES,2018,third_quarter,PHA,Prescription Drug User Fee,"HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2018-10-18T09:49:01.607000-04:00
2189922,53f8389c-ce29-45ac-b76e-64371bc00b18,Q3,"RUBICON ADVISORS, LLC",315091,"DR. REDDY'S LABORATORIES, LTD",2018,third_quarter,PHA,Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues,"Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",45000,,0,0,2018-10-18T09:52:08.403000-04:00
2189942,684cfbcf-efa8-4348-aa60-765cf25f28e5,Q3,"RUBICON ADVISORS, LLC",315091,CONSCIOUS DISCIPLINE,2018,third_quarter,PHA,Medicare,"HOUSE OF REPRESENTATIVES,SENATE",37500,,0,0,2018-10-18T09:54:18.247000-04:00
2189959,77e5eae0-eda9-4dc7-9abe-25b351271374,Q3,"RUBICON ADVISORS, LLC",315091,"LANNETT COMPANY, INC",2018,third_quarter,PHA,"Medicare and Medicaid, Generic Prescription","HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2018-10-18T09:56:23.793000-04:00
2189961,9947f386-a194-4fb8-998f-d4927fed7315,Q3,HOLLAND & KNIGHT LLP,18466,THE BIOSIMILARS FORUM,2018,third_quarter,PHA,"Medicare reimbursement issues, FDA regulation of biosimilars.","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",120000,,0,0,2018-10-18T09:56:24.450000-04:00
2190075,7a570846-1e6c-4c69-872f-e5ef10bab449,Q3,ELI LILLY AND COMPANY,13392,ELI LILLY AND COMPANY,2018,third_quarter,PHA,Hospital discounts; 340B program,"Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)",,1930000,0,0,2018-10-18T10:15:00.513000-04:00
2190510,30330e10-872d-4654-9364-d426204fc19c,Q3,PRIME THERAPEUTICS,400339576,PRIME THERAPEUTICS,2018,third_quarter,PHA,"S.2460/H.R.3528: Every Prescription Conveyed Securely Act--provisions requiring electronic prescribing of controlled substances in Medicare Part D; provisions added through amendment to H.R. 6 that limit who can use analgesic prescribing guidelines(became HR 6, which is awaiting President's signature).  S.2554: ""Patient Right to Know Drug Prices Act,""--provisions to prohibit the use of gag clauses or require that beneficiaries be charged lower prices (now PL 115-263). H.R.5343: ""Prescription Transparency Act of 2018,""-- provisions to prohibit the use of gag clauses or require that beneficiaries be charged lower prices. H.R.5958: The Phair Pricing Act of 2018, provisions related to the use of quality provisions and provisions to prohibit the use of gag clauses or require that beneficiaries be charged lower prices. H.R.6144: Know the Lowest Price Act -provisions to prohibit the use of gag clauses or require that beneficiaries be charged lower prices. Request for Information: HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs, provisions affecting market competition for prescription drugs and the drug supply chain. H.R.5675: To amend title XVIII of the Social Security Act to require prescription drug plan sponsors under the Medicare program to establish drug management programs for at-risk beneficiaries; provisions mandating a Medicare lock-in program for Medicare beneficiaries at risk for opioid abuse.","HOUSE OF REPRESENTATIVES,SENATE",,40000,0,0,2018-10-18T10:53:29.830000-04:00
2190615,4c432625-bfe9-415e-931a-5600fd28358e,Q3,"NVG, LLC",76833,"MANATT, PHELPS AND PHILLIPS, LLP (ON BEHALF OF NEKTAR THERAPEUTICS)",2018,third_quarter,PHA,FDA oversight of certain pain reliever products.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-10-18T11:05:09.427000-04:00
2190756,51d9ed68-3fe9-4726-a7aa-6bbeeac7f970,Q3,GREATER NEW YORK HOSPITAL ASSOCIATION,16830,GREATER NEW YORK HOSPITAL ASSOCIATION,2018,third_quarter,PHA,"Preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases, including raising awareness about saline and local anesthetic shortages.

Oppose legislation that would harm the 340B Drug Discount Program for safety net hospitals and support legislation to prevents the implementation of the cuts in CMS Final 2017 OPPS Rule (CMS-2017-0091), the SERV Communities Act (support) (H.R. 6071) and H.R. 4392 (support).

Support reforms aimed at creating more competition in the generic drug market, including ending pay for delay (S.124), and support other pro-competition policies, including legislation that would prohibit evergreening and abuse of citizen petitions, and promote the growth of biosimilars.

Supported legislation to increase competition in the drug marketplace and prevent REMS abuses, the CREATES Act (S. 974/H.R.2214) (support).

Raise awareness about generic injectable opioid shortages, urge engagement by the Food & Drug Administration Office of Drug Shortages and approval by the Drug Enforcement Agency of CII quota requests to increase production of injectable opioid products in short supply.

Submitted comments to DEA urging the revision of its quota allocation process to recognize the unique institutional needs for injectable opioids. Submitted comments to DEA opposing proposed aggregate quota reductions for CY 2018 Schedule II controlled substances.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),White House Office",,600000,0,0,2018-10-18T11:25:07.227000-04:00
2191022,972b33a7-e7ce-4adf-9ac2-64e43ebee295,Q3,BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC,401104621,BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC,2018,third_quarter,PHA,"HR 5202 - Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 , S. 916 - Protecting Patient Access to Emergency Medications Act of 2017: To amend the Controlled Substances Act to provide for the delivery of a controlled substance by a pharmacy to an administering practitioner.
S.2680 - Opioid Crisis Response Act of 2018, H.R.5176 - Preventing Overdoses While in Emergency Rooms Act of 2018, H.R.6 - SUPPORT for Patients and Communities Act - all relevant sections pertaining to opioid crisis","HOUSE OF REPRESENTATIVES,SENATE",,130000,0,0,2018-10-18T12:02:41.350000-04:00
2191161,b5828d74-1c73-4143-8aa7-47de815d63a2,Q3,BALLARD PARTNERS,401104288,LABORATORY CORPORATIONS OF AMERICA HOLDINGS,2018,third_quarter,PHA,Clinical Lab Rates,White House Office,80000,,0,0,2018-10-18T12:24:55.247000-04:00
2191331,3ebbb685-419a-47c1-a18f-93ed3bcc1979,Q3,ACG ADVOCACY,2057,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,2018,third_quarter,PHA,"Advocacy on Medicare and Medicaid pharmacy coverage and reimbursement issues. 
Advocating for coverage of pharmacists services under Medicare Part B. 
Advocating for the passage of legislation that curbs prescription drug abuse while protecting patient access to medication. 
Advocating for fair and accurate Medicaid pharmacy reimbursement. 
Advocating for Medicare Part D changes that increase beneficiary eligibility for medication therapy management.
Issues related to pharmacy reimbursement for 21st Century Cures.
Issues regarding TriCare coverage for pharmacies.
Issues regarding direct and indirect renumeration under Medicare Part D plans.","HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2018-10-18T13:07:59.787000-04:00
2191422,d0fb72fe-fe23-4cbc-8b7b-82edb74c4520,Q3,"MEHLMAN CONSULTING, INC.",284950,ASCENSION HEALTH ALLIANCE,2018,third_quarter,PHA,"Prescription drug pricing.
S. 974 - CREATES Act of 2017.
340B Drug Pricing Program.
H.R. 6 - SUPPORT for Patients and Communities Act.
S. 3120 - HEAL Act of 2018.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2018-10-18T13:18:26.677000-04:00
2191442,40784b93-c6f8-4cf6-8e47-74c39a3039c8,Q3,"MEHLMAN CONSULTING, INC.",284950,THE CAMPAIGN FOR SUSTAINABLE RX PRICING,2018,third_quarter,PHA,"Prescription drug pricing.
S. 974 - CREATES Act.
S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act
H.R. 2051 - FAST Generics Act of 2017
Medicare Part D Biosimilars.
H.R.6 - SUPPORT for Patients and Communities Act.
S. 2553: Know the Lowest Price Act of 2018.
S. 2554: Patient Right to Know Drug Prices Act.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2018-10-18T13:23:32.600000-04:00